Abstract Details
|
Megan G. Pino
PRESENTER |
Ms. Pino has nothing to disclose. |
| No disclosure on file | |
| Kelly Rich, MS, CGC | Ms. Rich has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Vibhor Krishna | No disclosure on file |
| Stephen J. Kolb, MD, PhD (The Ohio State University) | Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH. |